Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics

NCT01386970 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: zidovudine 300mg and lamivudine 150mg as Combivir

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]